EZH2 and neoplasm: After 14 days of treatment, tumors treated with EPZ-6438 alone had not increased in volume, and combination treated tumors grew initially, but began to regress at day 9, and ended with slightly lower tumor volumes than EZH2 inhibition alone (Fig. 5D).